Vascular Solutions management did say that launches of Silver versions of the D-Stat Dry and Thrombix products, which include a new antimicrobial ingredient, would enable the company to maintain hemostat market share.Ĭatheter sales continue to be Vascular Solution’s growth driver. The injunction would prevent HemCon from selling such products as the HemCon Bandage and the Chitoflex and Dental Dressings. Marine Polymer was awarded an injunction in September but Hemcon was subsequently given a stay. However, the company could see upside if Marine Polymer’s injunction against competitor HemCon is enforced. Management cited competitive pricing pressure for Vascular Solution’s D-Stat Dry product.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |